NL7003000A - - Google Patents

Info

Publication number
NL7003000A
NL7003000A NL7003000A NL7003000A NL7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A
Authority
NL
Netherlands
Application number
NL7003000A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7003000A publication Critical patent/NL7003000A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NL7003000A 1969-03-05 1970-03-03 NL7003000A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1626669 1969-03-05

Publications (1)

Publication Number Publication Date
NL7003000A true NL7003000A (xx) 1970-09-08

Family

ID=11911735

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003000A NL7003000A (xx) 1969-03-05 1970-03-03

Country Status (7)

Country Link
US (1) US3642978A (xx)
BR (1) BR7017141D0 (xx)
ES (1) ES377132A1 (xx)
FR (1) FR2060317B1 (xx)
GB (1) GB1238811A (xx)
NL (1) NL7003000A (xx)
SE (1) SE370624B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072667A (en) * 1971-12-22 1978-02-07 Hitachi, Ltd. Process for recovering microbial cellular proteins
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IE914007A1 (en) * 1990-11-19 1992-05-20 Univ Illinois A protein being genetically engineered to provide¹orientability and a substrate having an oriented layer of¹proteins
DE60115453T2 (de) * 2000-07-21 2006-08-24 Evotec Ag Verfahren zur detektion der apoptose durch ermittlung von cytochrom c als apoptosespezifischem marker, der durch zelluläre ausschüttungsvorgänge ins extrazelluläre medium abgegeben wird
WO2006088832A2 (en) * 2005-02-14 2006-08-24 The Children's Hospital Of Philadelphia Methods for the treatment of sepsis and sepsis-associated cardiac dysfunction
CN110507815B (zh) * 2019-09-30 2023-02-14 成都通德药业有限公司 注射用细胞色素c及其制备方法

Also Published As

Publication number Publication date
GB1238811A (xx) 1971-07-14
ES377132A1 (es) 1972-05-16
FR2060317A1 (xx) 1971-06-18
FR2060317B1 (xx) 1974-02-22
DE2010191A1 (de) 1970-09-10
SE370624B (xx) 1974-10-28
US3642978A (en) 1972-02-15
BR7017141D0 (pt) 1973-02-13

Similar Documents

Publication Publication Date Title
AU2270770A (xx)
AU465452B2 (xx)
AU429630B2 (xx)
AU450150B2 (xx)
AU2355770A (xx)
AU442375B2 (xx)
AU427401B2 (xx)
AU470301B1 (xx)
AU442380B2 (xx)
AU410358B2 (xx)
AU428074B2 (xx)
AU428129B2 (xx)
AU428131B2 (xx)
AU417208B2 (xx)
AU470661B1 (xx)
AU438128B2 (xx)
AU425297B2 (xx)
AU442285B2 (xx)
AU442322B2 (xx)
AU442357B2 (xx)
AU414607B2 (xx)
AU442554B2 (xx)
AU442463B2 (xx)
AU442535B2 (xx)
AU442538B2 (xx)